Weather forecast

CorMedix Inc (CRMD)

Clear blue sky

Buy

Score 80/100 · Confidence 85%

The outlook is bright — conditions favour stepping in.

Weighed fromlive price action

Why this call

Explosive Growth at a Low Price

The stock has been in a clear uptrend since hitting lows a month ago.

The company's very low valuation may continue to attract new buyers.

Underlying business growth and profitability are exceptionally strong.

Under the hood

What the engine weighed

Six factors, scored 0–100 from live market and financial data — the same read Wall Street does, minus the jargon.

0Overall score
Valuation
0

The stock's P/E ratio of 3.8 is exceptionally low, suggesting it's very cheap relative to earnings.

Growth
0

Recent revenue growth has been explosive, expanding by over 380%.

Profitability
0

The company is highly profitable, with an impressive net margin of over 45%.

Momentum
0

The stock has a positive one-month trend but is still well below its highs from the past year.

Fin. health
0

With a low debt-to-equity ratio of 0.33, the company's balance sheet appears solid.

Sentiment
0

There is no significant recent news to suggest a strong positive or negative market mood.

The argument

Both sides of the sky

Every call has a case against it. Here's the honest version of both.

The bull case

  • The company's valuation looks very attractive, with a price-to-earnings ratio of just 3.8.
  • Revenue has grown at an explosive rate of over 380% in the last year.
  • It operates with extremely high profit margins (45.3% net margin) and has low debt.

The bear case

  • The stock price is down significantly from its 52-week high of $17, indicating a weak long-term trend despite a recent recovery.
  • As a small pharmaceutical company, future success can depend heavily on a small number of products.
  • The stock is historically more volatile than the broader market, as shown by its Beta of 1.50.
Sunny, Tickerday's mascot, fast asleep under the stars

Get the full picture

That took thirty seconds. Now imagine every stock you own.

You just understood CRMD without reading a single chart. The Tickerday app does this for your whole watchlist — the full thesis, price targets from next week to next year, bull and bear scenarios — and wakes you the moment the weather turns.

One plain answer for every stock — Buy, Hold, or Sell

The full picture in seconds — thesis, targets & scenarios

Sleep easy — we watch the market and wake you if it turns

Download on the App StoreAnalyze any stock free

Free to download · 7-day free Tickerday+ trial inside

More forecasts

VOLAF · Volvo ABVOLCAR-B.ST · Volvo Car ABVOLV-A.ST · AB VolvoVOLV-B.ST · AB VolvoVZ · Verizon Communications IncWBA · Walgreens Boots Alliance, Inc.